On August 4, 2025, BayFirst Financial, the parent company of CreditBench, announced that they had discontinued their Bolt loan program, effective immediately. The Bolt loan program was an SBA 7(a) loan designed to provide small balance loans (up to $350,000) to small businesses, typically used for working capital. HealthGrowth (or PharmLine) will be announcing a competing product (offered by one of our preferred pharmacy lenders) on Friday, August 15, 2025, so stay tuned. In the interim, one of our lending professionals will be reaching out to you shortly to discuss how we can help you obtain the capital you need. Thank you for your patience!
Karl Kipke
CEO